CD8A and cancer: M2 macrophages (M2MAC), CD4+ follicular helper (TFH), T-17 helper (TH17), and CD8+ terminally exhausted cells (CD8TEREX) were observed to be specifically enriched in cancers when compared to benign and healthy tissues (Fig. 3D).